| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021924 |
| Receipt No. | R000025286 |
| Official scientific title of the study | A retrospective assessment of continuous positive airway pressure on arterial blood gases during one-lung ventilation |
| Date of disclosure of the study information | 2016/04/15 |
| Last modified on | 2016/04/15 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A retrospective assessment of continuous positive airway pressure on arterial blood gases during one-lung ventilation | |
| Title of the study (Brief title) | Effects of continuous positive airway pressure on arterial blood gases during one-lung ventilation | |
| Region |
|
|
| Condition | |||
| Condition | lung cancer,esophageal cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To measure changes in blood oxygen partial pressure for changing of administration oxygen concentration of CPAP during the one lung ventilation retrospectively. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | blood oxygen partial pressure during one-lung ventilation in 30 minutes |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with lung tumor or esophageal tumor | |||
| Key exclusion criteria | History of ischemic heart disease.
History of ischemic brain disease. NYHA (New York Heart Association) classification is greater than 2. Hugh-Jones classification is greater than 2. SPO2 is less than 95%. PaO2 is less than 70mmHg. BMIis greater than 29 kg/m2. ASA-PS classificationis greater than 2. |
|||
| Target sample size | 13 | |||
| Research contact person | |
| Name of lead principal investigator | Yuko Yamada |
| Organization | Gifu University Hospital |
| Division name | Department of Anesthesiology and pain medicine |
| Address | 1-1 yanagido gifu city |
| TEL | 058-230-6404 |
| y-comet@wg7.so-net.ne.jp | |
| Public contact | |
| Name of contact person | Yamada Yuko |
| Organization | Gifu University Hospital |
| Division name | Department of Anesthesiology and pain medicine |
| Address | 1-1 yanagido gifu city |
| TEL | 058-230-6404 |
| Homepage URL | |
| y-comet@wg7.so-net.ne.jp | |
| Sponsor | |
| Institute | Department of Anesthesiology and Pain medicine, Gifu University Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | no |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Continuous positive airway pressure of oxygen concentration 50% significantly improved arterial oxygenation during one-lung ventilation. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025286 |